IRWD Insider Trading Activity and SEC Form 4 Filings
IRWD insider trading summary
Over the past 12 months, insiders at Ironwood Pharmaceuticals Inc (IRWD) reported 18 sales worth $22.6M by 8 insiders and no open-market purchases on SEC Form 4. Net insider selling was $22.6M.
Latest IRWD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 7, 2026 | Ronald Silver | Pfo & Pao | Sell | $578K (127,890 @ $4.52) |
| Jun 16, 2026 | Julie McHugh | Insider | Sell | $80K (21,571 @ $3.73) |
| Mar 17, 2026 | Alexander J Denner | Insider | Sell | $19K (5,800 @ $3.31) |
| Mar 17, 2026 | Alexander J Denner | Insider | Sell | $20.5M (6,725,000 @ $3.05) |
| Feb 24, 2026 | Thomas A MCCOURT | Chief Executive Officer | Sell | $379K (103,526 @ $3.66) |
| Feb 24, 2026 | Minardo John | Chief Legal Officer | Sell | $70K (19,053 @ $3.66) |
| Feb 24, 2026 | Ronald Silver | Principal Accounting Officer | Sell | $46K (12,621 @ $3.66) |
| Feb 24, 2026 | Gregory S. Martini | Chief Financial Officer | Sell | $42K (11,457 @ $3.66) |
| Feb 24, 2026 | Tammi L Gaskins | Chief Commercial Officer | Sell | $41K (11,239 @ $3.66) |
| Feb 24, 2026 | Michael Shetzline | SVP, CMO, Head-Res&Drug | Sell | $62K (17,012 @ $3.66) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.